Sachs Adam DavidDirector · President
4
Filed Feb 24, 2026Period of report Feb 20, 20260001213900-26-019944
| Transaction | Security | Shares | Price | ValueValue (shares × price) | Held after | Ownership |
|---|---|---|---|---|---|---|
SaleFeb 20, 2026 | Class A Common StockF1F2 | 942 | $2.0878 | $1.97K | 46,943 | Direct |
Filing footnotes · 2
- F1The sales reported in this Form 4 were effected to cover tax withholding obligations in connection with the vesting of restricted stock units that were granted on May 19, 2022. The sale is mandated by the Issuer's election under its equity incentive plan to require the satisfaction of tax withholding obligations to be funded by a "sell to cover" transaction and does not represent a discretionary trade by the Reporting Person.
- F2This figure is the weighted average sales price of multiple trades ranging from $1.845 to $2.290 per share. The Reporting Person undertakes to provide the staff of the Securities Exchange Commission, Vicarious Surgical Inc. or any security holder of Vicarious Surgical Inc. full information about the number of shares sold at each separate price upon request.